| Registered Number: |
| England and Wales |
|
|
|
|
|
Period of accounts Start date: End date: |
|
OncoCDx Ltd.
|
|---|
|
OncoCDx Ltd.
|
||||||
|---|---|---|---|---|---|---|
1
|
|
OncoCDx Ltd.
|
|||
|---|---|---|---|
|
Director's report and financial statements
The directors present his/her/their report and accounts for the year ended 31 March 2026.
Directors
The directors who served the company throughout the year were as follows:
This report was approved by the board and signed on its behalf by:
Date approved: 2
|
|
OncoCDx Ltd.
|
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3
|
|
OncoCDx Ltd.
|
|||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOTES TO THE ACCOUNTS
General Information
OncoCDx Ltd. is a private company, limited by shares, registered in England and Wales, registration number 11683202, registration address 167-169 Great Portland Street, 5th Floor, London, England, W1W 5PF .
The presentation currency is £ sterling.
Directors' responsibilities: The financial statements were approved by the board of directors on
4
|
|||||||||||||||||||||||||||||||||||||||||||